The role of selenium nanoparticles (Se-NPs) in the mitigation of high-temperature (HT) stress in crops is not known. The uptake, toxicity and physiological and biological effects of Se-NPs under HT were investigated in grain sorghum [Sorghum bicolor (L.) Moench]. Se-NPs of size 10–40 nm were synthesized and characterized to indicate nanocrystalline structure. A toxicity assay showed that Se-NPs concentration inducing 50% cell mortality (TC50) was 275 mg L^–1. Translocation study indicated that Se-NPs can move from root to shoot of sorghum plants. Foliar spray of 10 mg L^–1 Se-NPs during the booting stage of sorghum grown under HT stress stimulated the antioxidant defense system by enhancing antioxidant enzymes activity. Furthermore, it decreased the concentration of signature oxidants. Se-NPs facilitated higher levels of unsaturated phospholipids. Se-NPs under HT stress improved the pollen germination percentage, leading to a significantly increased seed yield. The increased antioxidant enzyme activity and decreased content of oxidants in the presence of Se-NPs were greater under HT (38/28 °C) than under optimum temperature conditions (32/22 °C). In conclusion, Se-NPs can protect sorghum plants by enhanced antioxidative defense system under HT stress.

The targeted delivery of therapeutics to the tumor site is highly desirable in cancer treatment, because it is capable of minimizing collateral damage. Herein, we report the synthesis of a nanoplatform, which is composed of a 15 ± 1 nm diameter core/shell Fe/Fe₃O₄ magnetic nanoparticles (MNPs) and the topoisomerase I blocker SN38 bound to the surface of the MNPs via a carboxylesterase cleavable linker. This nanoplatform demonstrated high heating ability (SAR = 522 ± 40 W/g) in an AC-magnetic field. For the purpose of targeted delivery, this nanoplatform was loaded into tumor-homing double-stable RAW264.7 cells (mouse monocyte/macrophage-like cells (Mo/Ma)), which have been engineered to express intracellular carboxylesterase (InCE) upon addition of doxycycline by a Tet-On Advanced system. The nanoplatform was taken up efficiently by these tumor-homing cells. They showed low toxicity even at high nanoplatform concentration. SN38 was released successfully by switching on the Tet-On Advanced system. We have demonstrated that this nanoplatform can be potentially used for thermochemotherapy. We will be able to achieve the following goals: (1) Specifically deliver the SN38 prodrug and magnetic nanoparticles to the cancer site as the payload of tumor-homing double-stable RAW264.7 cells; (2) Release of chemotherapeutic SN38 at the cancer site by means of the self-containing Tet-On Advanced system; (3) Provide localized magnetic hyperthermia to enhance the cancer treatment, both by killing cancer cells through magnetic heating and by activating the immune system.

Magnetic nanoparticles have continuously gained importance for the purpose of magnetically-aided drug-delivery, magnetofection, and hyperthermia. We have summarized significant experimental approaches, as well as their advantages and disadvantages with respect to future clinical translation. This field is alive and well and promises meaningful contributions to the development of novel cancer therapies.